Drugs used for type 2 diabetes such as Vitamin E and pioglitazone, and Glucagon-like peptide-1 agonists (GLP-1) were also shown to be effective in controlling NAFLD/NASH symptoms [38]. The gene discussed is GLP1R; the disease is metabolic dysfunction-associated steatotic liver disease.